$1.21 Billion is the total value of BRIDGER MANAGEMENT, LLC's 30 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDCO | Sell | MEDICINES CO | $70,365,000 | -16.6% | 1,407,296 | -39.2% | 5.81% | -12.2% |
| HUM | Sell | HUMANA INC | $64,506,000 | -10.3% | 252,300 | -7.0% | 5.33% | -5.6% |
| GDS | Sell | GDS HLDGS LTDsponsored ads | $47,071,000 | -2.3% | 1,174,423 | -8.4% | 3.89% | +2.8% |
| HRTX | Sell | HERON THERAPEUTICS INC | $44,892,000 | -15.2% | 2,426,614 | -14.8% | 3.71% | -10.7% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $38,172,000 | -41.9% | 2,658,196 | -36.3% | 3.15% | -38.8% |
| HCA | Sell | HCA HEALTHCARE INC | $36,766,000 | -27.3% | 305,311 | -18.5% | 3.04% | -23.5% |
| SHAK | Sell | SHAKE SHACK INCcl a | $35,573,000 | -13.3% | 362,842 | -36.1% | 2.94% | -8.7% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $28,289,000 | -37.8% | 351,761 | -43.9% | 2.34% | -34.5% |
| CNC | Sell | CENTENE CORP DEL | $20,083,000 | -46.8% | 464,228 | -35.5% | 1.66% | -44.0% |
| DXCM | Sell | DEXCOM INC | $14,279,000 | -17.0% | 95,676 | -16.7% | 1.18% | -12.7% |
| TGTX | Sell | TG THERAPEUTICS INC | $13,107,000 | -55.6% | 2,334,196 | -31.6% | 1.08% | -53.3% |
| GDEN | Sell | GOLDEN ENTMT INC | $6,868,000 | -40.4% | 516,742 | -37.2% | 0.57% | -37.3% |
| CYCN | Exit | CYCLERION THERAPEUTICS INC | $0 | – | -1,032,633 | -100.0% | -0.93% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -653,141 | -100.0% | -1.34% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -1,247,366 | -100.0% | -1.47% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -1,083,598 | -100.0% | -3.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.